Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)
Clinical trial NCT06753890 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06753890
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2026-11-11
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.